Bayer Aktiengesellschaft (LON:0P6S)

Market Cap	32.51B
Revenue (ttm)	40.03B
Net Income (ttm)	-172.83M
Shares Out	n/a
EPS (ttm)	-0.18
PE Ratio	n/a
Forward PE	8.43
Dividend	0.09 (0.25%)
Ex-Dividend Date	Apr 28, 2025

Volume	1,383,378
Average Volume	1,004,608
Open	38.41
Previous Close	37.65
Day's Range	37.85 - 39.07
52-Week Range	18.37 - 38.20
Beta	0.83
RSI	78.10
Earnings Date	Feb 25, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 91,864
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0P6S

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR